控制温链(CTC)技术在Côte科特迪瓦大规模疫苗接种运动中的实践

D. Kouassi, L. Aka, B. V. J. Bénié, Soplé Ruth Coulibaly, Dodji Blaise Tagodé, D. Coulibaly, K. Koffi, P. Lydon, Anna-Léa Kahn, O. Ronveaux
{"title":"控制温链(CTC)技术在Côte科特迪瓦大规模疫苗接种运动中的实践","authors":"D. Kouassi, L. Aka, B. V. J. Bénié, Soplé Ruth Coulibaly, Dodji Blaise Tagodé, D. Coulibaly, K. Koffi, P. Lydon, Anna-Léa Kahn, O. Ronveaux","doi":"10.4236/WJV.2016.61003","DOIUrl":null,"url":null,"abstract":"Background: MenAfriVacTM is the first of the World Health Organization (WHO)’s pre-qualified vaccines to be allowed to mass vaccination campaign at a temperature below or equal to 40°C during 4 days. This new vaccination practice has already been used in some African countries. This article described the opinion and use of this new technique by actors on the field, during a mass vaccination campaign in Cote d’Ivoire, in December 2014. Methods: We conducted a crosssectional study on the practice of CTC by actors on the field and their perception on the new practice, during a mass vaccination campaign in 2 of 25 health districts in Cote d’Ivoire, in December 2014. Findings: As results, in Seguela 98.25% of respondents expressed a favourable opinion of CTC, citing advantages such as vaccine carriers requiring no ice packs (29.2%), financial benefit (12.28%) and lighter vaccine carriers (5.26%). In Bouna, respondents gave the same advantages in, respectively, 34%, 2% and 8% of cases. The peak of the total of vials used for immunization sessions reached 376 vials at day one, then dropped to 235 vials at day three and 220 vials at day six. Discussion: Vaccinators found some benefits related to CTC practice, but on the field, they were cautious in using CTC technique.","PeriodicalId":57190,"journal":{"name":"疫苗(英文)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Practice of Controlled Temperature Chain (CTC) Technique during a Mass Vaccination Campaign in Côte d’Ivoire\",\"authors\":\"D. Kouassi, L. Aka, B. V. J. Bénié, Soplé Ruth Coulibaly, Dodji Blaise Tagodé, D. Coulibaly, K. Koffi, P. Lydon, Anna-Léa Kahn, O. Ronveaux\",\"doi\":\"10.4236/WJV.2016.61003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: MenAfriVacTM is the first of the World Health Organization (WHO)’s pre-qualified vaccines to be allowed to mass vaccination campaign at a temperature below or equal to 40°C during 4 days. This new vaccination practice has already been used in some African countries. This article described the opinion and use of this new technique by actors on the field, during a mass vaccination campaign in Cote d’Ivoire, in December 2014. Methods: We conducted a crosssectional study on the practice of CTC by actors on the field and their perception on the new practice, during a mass vaccination campaign in 2 of 25 health districts in Cote d’Ivoire, in December 2014. Findings: As results, in Seguela 98.25% of respondents expressed a favourable opinion of CTC, citing advantages such as vaccine carriers requiring no ice packs (29.2%), financial benefit (12.28%) and lighter vaccine carriers (5.26%). In Bouna, respondents gave the same advantages in, respectively, 34%, 2% and 8% of cases. The peak of the total of vials used for immunization sessions reached 376 vials at day one, then dropped to 235 vials at day three and 220 vials at day six. Discussion: Vaccinators found some benefits related to CTC practice, but on the field, they were cautious in using CTC technique.\",\"PeriodicalId\":57190,\"journal\":{\"name\":\"疫苗(英文)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"疫苗(英文)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4236/WJV.2016.61003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"疫苗(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/WJV.2016.61003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

背景:MenAfriVacTM是世界卫生组织(WHO)预审合格疫苗中第一个被允许在低于或等于40°C的温度下进行为期4天的大规模疫苗接种运动的疫苗。这种新的疫苗接种做法已在一些非洲国家使用。本文描述了2014年12月科特迪瓦大规模疫苗接种运动期间现场行动者对这项新技术的看法和使用情况。方法:2014年12月,在科特迪瓦25个卫生区中的2个区开展大规模疫苗接种运动期间,我们对现场行动者的CTC实践及其对新做法的看法进行了横断面研究。结果:在Seguela, 98.25%的受访者对CTC表示赞成,认为其优点包括疫苗载体不需要冰袋(29.2%)、经济效益(12.28%)和更轻的疫苗载体(5.26%)。在Bouna,受访者分别在34%、2%和8%的情况下给出了相同的优势。用于免疫接种的总药瓶在第1天达到峰值376瓶,然后在第3天和第6天下降到235瓶和220瓶。讨论:接种人员发现了与CTC实践相关的一些好处,但在现场,他们对使用CTC技术持谨慎态度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Practice of Controlled Temperature Chain (CTC) Technique during a Mass Vaccination Campaign in Côte d’Ivoire
Background: MenAfriVacTM is the first of the World Health Organization (WHO)’s pre-qualified vaccines to be allowed to mass vaccination campaign at a temperature below or equal to 40°C during 4 days. This new vaccination practice has already been used in some African countries. This article described the opinion and use of this new technique by actors on the field, during a mass vaccination campaign in Cote d’Ivoire, in December 2014. Methods: We conducted a crosssectional study on the practice of CTC by actors on the field and their perception on the new practice, during a mass vaccination campaign in 2 of 25 health districts in Cote d’Ivoire, in December 2014. Findings: As results, in Seguela 98.25% of respondents expressed a favourable opinion of CTC, citing advantages such as vaccine carriers requiring no ice packs (29.2%), financial benefit (12.28%) and lighter vaccine carriers (5.26%). In Bouna, respondents gave the same advantages in, respectively, 34%, 2% and 8% of cases. The peak of the total of vials used for immunization sessions reached 376 vials at day one, then dropped to 235 vials at day three and 220 vials at day six. Discussion: Vaccinators found some benefits related to CTC practice, but on the field, they were cautious in using CTC technique.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
95
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信